Study Shows How Companies Can Help Safeguard Intellectual Property When Expanding into Risky Countries
In 2015, Pfizer pharmaceutical company invested $14 million in Chile to launch the Center of Excellence in Precision Medicine, focusing on developing new genome-based diagnostic technologies for cancer.
This is just one example of a firm’s geographic entry into a country that does not have strong intellectual property rights protection. The country may provide important necessary resources, but the investing firm may suffer intellectual property leakage and imitation by competitors.
New research from the University of Notre Dame, however, shows there are ways companies like Pfizer can safeguard their intellectual property in such environments. “Fearlessly Swimming Upstream to Risky Waters: The Role of Geographic Entry in Innovation” is forthcoming in the Journal of Management Studies from Tim Hubbard, assistant professor of management in the University of Notre Dame’s Mendoza College of Business.
Read more here.
May 7, 2018